Management of COVID-19 pneumonia in a child with NEMO deficiency

Immunol Res. 2021 Aug;69(4):391-393. doi: 10.1007/s12026-021-09184-6. Epub 2021 Jun 1.

Authors

Gulsum Alkan¹, Hasibe Artac², Sadiye Kubra Tuter Oz³, Melike Emiroglu³

Affiliations

¹ Department of Pediatric Infectious Diseases, Faculty of Medicine, Selcuk University, Konya, Turkey. [email protected].
² Department of Pediatric Immunology and Allergy, Faculty of Medicine, Selcuk University, Konya, Turkey.
³ Department of Pediatric Infectious Diseases, Faculty of Medicine, Selcuk University, Konya, Turkey.

No abstract available

Publication types

Case Reports

MeSH terms

Amides / therapeutic use
Antiviral Agents / therapeutic use*
Azithromycin / therapeutic use
COVID-19 / complications
COVID-19 / pathology
COVID-19 / therapy*
COVID-19 Serotherapy
Child
Ectodermal Dysplasia / complications
Ectodermal Dysplasia / pathology*
Genetic Diseases, X-Linked / complications
Genetic Diseases, X-Linked / pathology*
Humans
Hydroxychloroquine / therapeutic use
I-kappa B Kinase / genetics
Immunization, Passive
Male
Primary Immunodeficiency Diseases / complications
Primary Immunodeficiency Diseases / pathology*
Pyrazines / therapeutic use
SARS-CoV-2

Substances

Amides
Antiviral Agents
IKBKG protein, human
Pyrazines
Hydroxychloroquine
Azithromycin
I-kappa B Kinase
favipiravir

Supplementary concepts

NEMO mutation with immunodeficiency